Contributions to Hypertension With Androgen Deprivation Therapy

NCT05700903 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Androgen Deprivation Therapy
Prostate Cancer
Hypertension
Autonomic Dysfunction
Renal Disease

Interventions

DRUG: Gonadotropin Releasing Hormone Agonists (GNRH)
DRUG: Androgen receptor (AR) inhibitor
DRUG: Placebo

Sponsor

University of Colorado, Denver